Coronavirus (COVID-19)
Beginning Thursday March 3, 2022 at 6:30 am, non-Covid-19 patients at Huntsville
Memorial Hospital will be allowed
TWO
healthy visitors at a time with the expectation that the visitors and the patient will be masked
at all times.
Visitor Rules and Guidelines
- Visitors must be 12+.
- All approved visitors will be screened for temperature, respiratory symptoms
and possible exposure upon entry to the hospital.
- Visitors will not be granted access if screening is failed or refused.
- Visitors will be fitted with a screening bracelet, which must be worn at
all times during the visit.
- Visitors are required to wear an FDA-approved mask and practice social
distancing.
- Visitors are required to stay in the patient’s room during their visit.
- Hand sanitizing will be required upon entry to the facility and at intermittent
locations.
- In the interest of infection control, the visiting of multiple patients
by one person will not be allowed.
- Visitation may be limited for COVID-19 patients- visitors should check
with the patient's unit or nurse prior to arrival at the hospital.
- Visitation for End or Life or Special Circumstances require AOC Approval
Visitation Policies and Procedures
- Visiting hours are from 6:30 a.m. to 7 p.m. seven days a week in non-critical
care areas.
- Surgical procedure visitors may escort the patient to registration and
remain in the designated waiting rooms/lobbies during the patient’s
procedure.
- Outpatient Procedures / Testing - Please limit bringing visitors with you
for testing, treatment and therapy unless needed. Visitors will be subject
to the screening and protection criteria.
- Women & Children’s Health Services visitation guidelines have
been developed to reflect the unique needs of the population served.
- Visitors & Outpatient Procedures / Testing Patients should use the
Main Entrance of the Hospital for entrance.
Liability Disclaimer
Though Huntsville Memorial Hospital has taken every known precaution to
reduce the spread of COVID-19, the contagious nature of the coronavirus
means that a possibility remains that you could still contract the virus
while in any public place, including the hospital. Please follow the guidelines
set out by staff and signage to protect yourself and decrease the risk
of exposure. HMH assumes no responsibility should transmission of coronavirus/COVID-19
occur during any visitation of the hospital facility.
Important Ways to Slow the Spread
[2].jpeg)
**please call your primary care physician to see if you qualify for treatment.**
WHO QUALIFIES FOR TREATMENT?
You may be eligible for this treatment if you have tested positive for
COVID-19, are 12 years of age or older (and at least 88 pounds), and are
at a greater risk of developing severe COVID-19 symptoms.
High risk for progressing to severe COVID-19 and/or hospitalization is
defined as patients who meet at least one of the following criteria:
- Have a body mass index (BMI) ≥25
- Have chronic kidney disease
- Have diabetes
- Have immunosuppressive disease
- Are currently receiving immunosuppressive treatment
- Are ≥65 years of age
- Are ≥55 years of age AND have
- cardiovascular disease, or
- hypertension, or
- chronic obstructive pulmonary disease/other chronic respiratory disease.
- Are 12 – 17 years of age AND have
- BMI ≥85th percentile for their age and gender based on CDC growth charts,
https://www.cdc.gov/growthcharts/clinical_charts.htm, or
- sickle cell disease, or
- congenital or acquired heart disease, or
- neurodevelopmental disorders, for example, cerebral palsy, or
- a medical-related technological dependence, for example, tracheostomy,
gastrostomy, or positive pressure ventilation (not related to COVID-19), or
- asthma, reactive airway or other chronic respiratory disease that requires
daily medication for control.
Information to order MAB infusion:
ALL patients will be required to have a POSITIVE Covid swab result on file
at HMH, so a test MAY be required prior to infusion at HMH Infusion Center.
If you have any questions regarding the treatment, please call
936-291-4574.
These medications are NOT approved for use in patents who are hospitalized
due to COVID-19 or require oxygen therapy. Benefits of treatment have
not been observed in patients hospitalized due to COVID-19. Monoclonal
antibodies may be associated with worse clinical outcomes when given to
patients with COVID-19 requiring oxygen ventilation.
Useful Links:
CDC website
Texas Department of Health Services - DSHS has a decidated call center that is available Monday through Friday
from 7:00 a.m. to 6:00 p.m. For more information, please call 1-877-570-9779.
Cases & Latest Updates
Walker County Office of Emergency Management